This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Weiguo Han: Innovator in Genomic DNA Sequencing
Introduction
Weiguo Han is a notable inventor based in Menands, NY (US). He has made significant contributions to the field of genomic DNA sequencing, particularly in the area of DNA methylation evaluation. His innovative methods have the potential to enhance the understanding of genetic factors in diseases.
Latest Patents
Weiguo Han holds a patent for a groundbreaking invention titled "GC tag-modified bisulfite genomic DNA sequencing for continuous methylation spectra." This invention relates to a tag-modified bisulfite genomic sequencing (tBGS) method developed for simplified evaluation of DNA methylation sites. The method employs direct cycle sequencing of PCR products at kilobase scale, eliminating the need for conventional DNA fragment cloning. It involves subjecting bisulfite-modified genomic DNA to a second-round PCR amplification using GC-tagged primers. Additionally, the invention includes a method for identifying patients at risk for lung cancer using the tBGS technique disclosed.
Career Highlights
Throughout his career, Weiguo Han has demonstrated a commitment to advancing genomic research. His innovative approaches have garnered attention in the scientific community, contributing to the understanding of DNA methylation and its implications in various health conditions.
Collaborations
Weiguo Han has collaborated with esteemed colleagues, including Simon Daniel Spivack and James Gordon Herman. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.
Conclusion
Weiguo Han's contributions to genomic DNA sequencing and his innovative methods for evaluating DNA methylation are noteworthy. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in the realm of cancer detection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile